Our analysis also identified several antigen-presenting molecules as potential cancer drivers, including one class I (HLA-C), one class II (HLA-DRB1), and three HLA-like proteins (CD1C, CD1E and MR1). The gene discussed is HLA-C; the disease is cancer.